(Q38876841)

7 September 2017

Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda (English)

1 reference

7 September 2017

0 references

visceral leishmaniasis

1 reference

1 reference

Y Mueller

1

1 reference

7 September 2017

A Nguimfack

2

1 reference

7 September 2017

P Cavailler

3

1 reference

7 September 2017

S Couffignal

4

1 reference

7 September 2017

J B Rwakimari

5

1 reference

7 September 2017

L Loutan

6

1 reference

7 September 2017

F Chappuis

7

1 reference

7 September 2017

1 January 2008

1 reference

Annals of Tropical Medicine and Parasitology

7 September 2017

1 reference

7 September 2017

102

1 reference

7 September 2017

1

1 reference

7 September 2017

11-19

1 reference

Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.

7 September 2017

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

Liposomal amphotericin B for the treatment of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

A policy for leishmaniasis with respect to the prevention and control of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

Nephrotoxicity of amphotericin B desoxycholate

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

Must we really fear toxicity of conventional amphotericin B in oncological patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

The world's most neglected diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485908X252142

21 January 2018

Identifiers

DOI

10.1179/136485908X252142

1 reference

7 September 2017

1 reference